BCL2L2 and cancer: Current evidence suggests that the B-cell lymphoma 2 homolog, BCL2-like 2 (BCL2L2; also known as Bcl-w) enhances tumorigenicity and cell survival through its anti-apoptotic activity in cancer cells [4–7].